Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows provided by (used in) operating activities:
Net income	$ 67,962	$ 55,164
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	79,363	66,430
Amortization of debt discount and debt issuance costs	1,413	1,347
Rationalization charges	10,959	11,691
Stock compensation expense	4,380	4,115
Other changes that provided (used) cash:
Trade accounts receivable, net	(404,478)	(355,645)
Inventories	(115,166)	(22,319)
Trade accounts payable	(281,591)	(281,165)
Accrued liabilities	(33,346)	(30,041)
Other, net	(12,897)	2,613
Net cash (used in) operating activities	(683,401)	(547,810)
Cash flows provided by (used in) investing activities:
Capital expenditures	(82,924)	(75,258)
Proceeds from asset sales	52	2,495
Other, net	400	301
Net cash (used in) investing activities	(82,472)	(72,462)
Cash flows provided by (used in) financing activities:
Borrowings under revolving loans	1,110,508	597,879
Repayments under revolving loans	(6,107)	(15,469)
Repayment of principal amounts under finance leases	(1,348)	(346)
Repayments of long-term debt	(706,274)	(100,000)
Changes in outstanding checks - principally vendors	(84,971)	(160,576)
Dividends paid on common stock	(21,939)	(21,137)
Repurchase of common stock	(6,873)	(7,675)
Net cash provided by financing activities	282,996	292,676
Effect of exchange rate changes on cash and cash equivalents	13,053	(6,686)
Cash and cash equivalents:
Net (decrease)	(469,824)	(334,282)
Balance at beginning of year	822,854	642,923
Balance at end of period	353,030	308,641
Interest paid, net	50,594	50,290
Income taxes paid, net	$ 12,175	$ 17,003